Companies / United Kingdom
R&D On The Up
April 2007 | Industry NewsA new report from the Association of the British Pharmaceutical Industry (ABPI) suggests that the UK is punching above its weight in terms of drug development. In 2006, there were 951 compounds in clinical development, compared to a total of 561 in 2002. This is partly due to the country's world class R&D facilities and advanced regulatory system. In fact,
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
